Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
Chin Med J (Engl). 2009 Aug 20;122(16):1895-900.
Lymphangioleiomyomatosis (LAM) is a rare disease that predominantly affects young females. It is considered as an "orphan" life-threatening disease of unknown etiology, with uncertain clinical prognosis, and no effective treatment. LAM can arise sporadically or in association with tuberous sclerosis complex (TSC), an autosomal inherited syndrome characterized by hamartoma-like tumor growth and pathologic features that are distinct from manifestations of pulmonary LAM. The clinical course of LAM is characterized by progressive dyspnea on exertion, recurrent pneumothorax, and chylous fluid collections.
Fourteen cases of LAM from Zhongshan Hospital, Fudan University are reviewed, twelve were confirmed by lung biopsy, one by retroperitoneal lymphangioleiomyoma resection, and one by autopsy.
All 14 patients were women, aged 18 to 69 years (mean 43.3 years, median 46.5 years). Haemoptysis (57.1%) and chylothorax (35.7%) were more frequent than those described in previous case series. Extrapulmonary findings such as renal angiomyolipoma (AML), enlarged abdominal lymph nodes, liver AML and retroperitoneal lymphangioleiomyoma were seen in 21.4%, 14.3%, 7.14% and 7.14% in 14 cases respectively, which is remarkably lower than in the previously reported. Abnormal smooth muscle cells (LAM cells) were found to line the airways, bronchioles, lymphatics and blood vessels leading to airflow obstruction and replacement of the lung parenchyma by cysts. There were some surprises in the autopsy case as several LAM cell emboli were found in the veins of mediastinum lymph nodes; LAM cells were found to be disseminated in soft tissues adjacent to the ilium.
Women with unexplained recurrent pneumothorax, tuberous sclerosis, or a diagnosis of primary spontaneous pneumothorax or emphysema in the setting of limited or absent tobacco use should undergo high-resolution computed tomography (HRCT) scan screening for LAM. Routine abdominal and pelvic imaging examinations should be performed to detect extrapulmonary involvement. The autopsy studies histologically suggested that LAM could be a multisystemic disease and LAM cells might possess metastatic potential.
淋巴管平滑肌瘤病(LAM)是一种罕见疾病,主要影响年轻女性。它被认为是一种病因不明、危及生命的“孤儿病”,临床预后不确定,且尚无有效治疗方法。LAM 可散发发生,也可与结节性硬化症复合征(TSC)相关,后者是一种常染色体遗传性综合征,其特征为错构瘤样肿瘤生长和病理学特征,与肺 LAM 的表现不同。LAM 的临床病程表现为进行性劳力性呼吸困难、复发性气胸和乳糜胸积液。
回顾复旦大学中山医院的 14 例 LAM 病例,其中 12 例经肺活检证实,1 例经腹膜后淋巴管平滑肌瘤瘤切除术证实,1 例经尸检证实。
所有 14 例患者均为女性,年龄 18 至 69 岁(平均 43.3 岁,中位数 46.5 岁)。咯血(57.1%)和乳糜胸(35.7%)比以前的病例系列更常见。14 例中分别有 21.4%、14.3%、7.14%和 7.14%存在肾血管平滑肌脂肪瘤(AML)、增大的腹部淋巴结、肝 AML 和腹膜后淋巴管平滑肌瘤瘤等肺外表现,明显低于以往报道。气道、细支气管、淋巴管和血管中存在异常平滑肌细胞(LAM 细胞),导致气流阻塞和肺实质被囊肿替代。尸检病例中有一些意外发现,纵隔淋巴结静脉中发现了几个 LAM 细胞栓子;LAM 细胞被发现散布在靠近髂骨的软组织中。
对于不明原因反复发作性气胸、结节性硬化症、或在无或有限吸烟史的情况下诊断为原发性自发性气胸或肺气肿的女性,应进行高分辨率计算机断层扫描(HRCT)筛查以发现 LAM。应进行常规腹部和盆腔影像学检查以发现肺外受累。尸检研究从组织学上提示 LAM 可能是一种多系统疾病,LAM 细胞可能具有转移潜能。